Table 1.
Demographics and clinical variables of the groups
| Characteristic | Patients with HCC (n = 68) | Cirrhosis patients (n = 31) | Controls(n = 33) |
| Age (yr), mean ± SD | 69.1 ± 10.1 | 59.3 ± 6.3 | 51.4 ± 12.6 |
| Sex% (M/F) | 47 (69.1)/21 (30.9) | 17 (54.8)/14 (45.2) | 16 (48.5)/17 (51.5) |
| Platelet (× 1000/mm3) | 175 (27-413) | 88 (45-120) | 256 (181-396) |
| Hb (g/dL) | 11.92 ± 1.80 | 9.2 ± 1.40 | 12.67 ± 1.63 |
| INR | 1.18 (0.10-2.10) | 1.10 (0,90-1.60) | - |
| Total bilirubin (mg/dL) | 2.0 (0.30-16.90) | 1.17 (0.90-3.00) | 0.80 (0.30-2.00) |
| Albumin (g/dL) | 3.2 (2-4.6) | 3.49 (2.3-4.4) | 4.4 (4-5.3) |
| Prolidase (U/L) median (min-max) | 1179 (1080-1600) | 913 (811-1011) | 880 (816-969) |
| AFP (ng/mL) median (min-max) | 650 (2.5-2300) | 14 (2-40) | 4.2 (1-16) |
| Underlying liver disease | |||
| HBV | 34 | 11 | |
| HCV | 18 | 6 | |
| NASH | 12 | 10 | |
| Alcohol | 4 | 4 | |
HCC: Hepatocellular carcinoma; Hb: Hemoglobin; AFP: α-fetoprotein; HBV: Hepatitis B virus; HCV: Hepatitis C virus; INR: International normalized ratio; NASH: Nonalcoholic steatohepatitis.